Suzuki Y, Kawasaki T, Tatsumi K, Okaya T, Sato S, Shimada A
Int J Mol Sci. 2024; 25(23).
PMID: 39684311
PMC: 11640941.
DOI: 10.3390/ijms252312599.
Chen C, Qin S, Song X, Wen J, Huang W, Sheng Z
Mol Med. 2024; 30(1):208.
PMID: 39528930
PMC: 11552344.
DOI: 10.1186/s10020-024-00975-9.
Fang X, Chen J, Hu Z, Shu L, Wang J, Dai M
J Am Heart Assoc. 2024; 13(19):e035868.
PMID: 39344593
PMC: 11681457.
DOI: 10.1161/JAHA.124.035868.
Liu T, Xu S, Yang J, Xing X
Rev Cardiovasc Med. 2024; 25(6):217.
PMID: 39076325
PMC: 11270120.
DOI: 10.31083/j.rcm2506217.
Hu P, Du Y, Xu Y, Ye P, Xia J
Front Cardiovasc Med. 2024; 11:1384294.
PMID: 38745757
PMC: 11091331.
DOI: 10.3389/fcvm.2024.1384294.
A scoping review of echocardiographic and lung ultrasound biomarkers of bronchopulmonary dysplasia in preterm infants.
Martini S, Corsini I, Corvaglia L, Suryawanshi P, Chan B, Singh Y
Front Pediatr. 2023; 11:1067323.
PMID: 36846161
PMC: 9950276.
DOI: 10.3389/fped.2023.1067323.
Systemic Hypoxemia Induces Cardiomyocyte Hypertrophy and Right Ventricular Specific Induction of Proliferation.
Johnson J, Yang Y, Bian Z, Schena G, Li Y, Zhang X
Circ Res. 2023; 132(6):723-740.
PMID: 36799218
PMC: 10023496.
DOI: 10.1161/CIRCRESAHA.122.321604.
Mechanism of Hypoxia-Mediated Smooth Muscle Cell Proliferation Leading to Vascular Remodeling.
Huang X, Akgun E, Mehmood K, Zhang H, Tang Z, Li Y
Biomed Res Int. 2023; 2022:3959845.
PMID: 36593773
PMC: 9805398.
DOI: 10.1155/2022/3959845.
Xinyang Tablet attenuates chronic hypoxia-induced right ventricular remodeling via inhibiting cardiomyocytes apoptosis.
Gao A, Li S, Tan X, Huang T, Dong H, Xue R
Chin Med. 2022; 17(1):134.
PMID: 36471367
PMC: 9720925.
DOI: 10.1186/s13020-022-00689-2.
Effects of dexmedetomidine on oxygenation and inflammatory factors in patients undergoing uvulopalatopharyngoplasty: a prospective, randomized, placebo-controlled trial.
Li N, Zhang Y, Yang F, Zhang H, Yu X, Lu K
Sleep Breath. 2022; 27(3):1099-1106.
PMID: 36166132
DOI: 10.1007/s11325-022-02711-1.
The role of p53 in the alternation of vascular functions.
Chan G, Chan E, Kwok C, Leung G, Lee S, Seto S
Front Pharmacol. 2022; 13:981152.
PMID: 36147350
PMC: 9485942.
DOI: 10.3389/fphar.2022.981152.
Evaluating the therapeutic role of selected active compounds in on pulmonary hypertension network pharmacology and experimental analysis.
Xiao X, Luo F, Fu M, Jiang Y, Liu S, Liu B
Front Pharmacol. 2022; 13:977921.
PMID: 36059960
PMC: 9428143.
DOI: 10.3389/fphar.2022.977921.
Aldehyde Dehydrogenase 2 (ALDH2) Elicits Protection against Pulmonary Hypertension via Inhibition of ERK1/2-Mediated Autophagy.
Chang S, Wu J, Jin J, Shi H, Gao R, Li X
Oxid Med Cell Longev. 2022; 2022:2555476.
PMID: 35770049
PMC: 9236760.
DOI: 10.1155/2022/2555476.
Maladaptive Pulmonary Vascular Responses to Chronic Sustained and Chronic Intermittent Hypoxia in Rat.
Prieto-Lloret J, Olea E, Gordillo-Cano A, Docio I, Obeso A, Gomez-Nino A
Antioxidants (Basel). 2022; 11(1).
PMID: 35052557
PMC: 8773044.
DOI: 10.3390/antiox11010054.
Physiology in Perspective: The New Normal-Life in a Pandemic.
Sieck G
Physiology (Bethesda). 2020; 35(4):220-221.
PMID: 32490749
PMC: 7276975.
DOI: 10.1152/physiol.00014.2020.
Know your enemy: understanding the pathophysiology of pulmonary hypertension.
Shimoda L
Am J Physiol Lung Cell Mol Physiol. 2020; 318(5):L995-L997.
PMID: 32233788
PMC: 7272741.
DOI: 10.1152/ajplung.00111.2020.